Standard Therapy Clinical Trials

4 actively recruiting trials across 1 location

▼ -1 trial since July 2026

Also known as: Azacitidine + venetoclax for AML patients. Azacitidine for MDS patients., Paclitaxel (Taxol); Doxorubicin (Adriamycin), TCbHP, THP, EC-THP, AC-THP

Pipeline

Phase 2: 3

Top Sponsors

University Hospital, Akershus1
Shengjing Hospital1
QuantumLeap Healthcare Collaborative1
Medical University of Warsaw1

Indications

Cancer3
Breast Cancer2
Cardiomegaly1
Heart Disease1
Hormone Receptor Negative Tumor1

Other3 trials

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies

Phase 2

Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

Phase 2

The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.

Birmingham, Alabama1 trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.